Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT01149044




Registration number
NCT01149044
Ethics application status
Date submitted
22/06/2010
Date registered
23/06/2010
Date last updated
20/10/2015

Titles & IDs
Public title
A Trial of Routine Aspiration Thrombectomy With Percutaneous Coronary Intervention (PCI) Versus PCI Alone in Patients With ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Primary PCI
Scientific title
TOTAL Trial: A Randomized Trial of Routine Aspiration ThrOmbecTomy With PCI Versus PCI ALone in Patients With STEMI Undergoing Primary PCI
Secondary ID [1] 0 0
TOTAL Trial
Universal Trial Number (UTN)
Trial acronym
TOTAL
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Acute Coronary Syndrome 0 0
ST Elevation Myocardial Infarction 0 0
Percutaneous Coronary Intervention 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease
Cardiovascular 0 0 0 0
Other cardiovascular diseases

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Active comparator: Upfront Thrombectomy followed by PCI - Upfront manual aspiration thrombectomy followed by PCI

Active comparator: PCI Alone - PCI without upfront manual aspiration thrombectomy
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
The first occurrence of cardiovascular death, recurrent myocardial infarction, cardiogenic shock, or new or worsening NYHA Class IV heart failure
Timepoint [1] 0 0
up to 180 days
Secondary outcome [1] 0 0
Stroke
Timepoint [1] 0 0
up to 30 days
Secondary outcome [2] 0 0
Key Net Benefit Outcome: The first occurence of CV death, MI, stroke, cardiogenic shock or new or worsening NHYA Class IV heart failure
Timepoint [2] 0 0
up to 1 year
Secondary outcome [3] 0 0
Cardiovascular Mortality
Timepoint [3] 0 0
up to 180 days
Secondary outcome [4] 0 0
Key Secondary Efficacy Outcome: The first occurence of cardiovascular death, myocardial infarction, cardiogenic shock, new or worsening NYHA class IV heart failure, stent thrombosis and target vessel revascularization
Timepoint [4] 0 0
up to 180 days

Eligibility
Key inclusion criteria
1. Patients presenting with:

* Symptoms of myocardial ischemia lasting for = 30 minutes AND
* Definite ECG changes indicating STEMI: ST elevation of greater than 0.1 mV in two contiguous limb leads or 0.2 mV in two contiguous precordial leads
2. Referred for primary PCI
3. Randomized within 12 hours of symptoms onset and prior to diagnostic angiography
4. Informed consent
Minimum age
19 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
1. Age = 18 years
2. Prior coronary artery bypass surgery (CABG)
3. Life expectancy less than six months due to non-cardiac condition
4. Treatment with fibrinolytic therapy for qualifying index STEMI event

Study design
Purpose of the study
Treatment
Allocation to intervention
Randomised controlled trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/08/2010
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/10/2015
Sample size
Target
Accrual to date
Final
10732
Recruitment in Australia
Recruitment state(s)
NSW,QLD
Recruitment hospital [1] 0 0
Royal North Shore Hospital - Sydney
Recruitment hospital [2] 0 0
St. George Public Hospital - Sydney
Recruitment hospital [3] 0 0
Gold Coast Hospital - Southport
Recruitment postcode(s) [1] 0 0
- Sydney
Recruitment postcode(s) [2] 0 0
- Southport
Recruitment outside Australia
Country [1] 0 0
United States of America
State/province [1] 0 0
California
Country [2] 0 0
United States of America
State/province [2] 0 0
Georgia
Country [3] 0 0
United States of America
State/province [3] 0 0
New Mexico
Country [4] 0 0
United States of America
State/province [4] 0 0
Ohio
Country [5] 0 0
United States of America
State/province [5] 0 0
Pennsylvania
Country [6] 0 0
Austria
State/province [6] 0 0
Vienna
Country [7] 0 0
Belgium
State/province [7] 0 0
Lige
Country [8] 0 0
Brazil
State/province [8] 0 0
RS
Country [9] 0 0
Brazil
State/province [9] 0 0
Santa Catarina
Country [10] 0 0
Brazil
State/province [10] 0 0
Sao Paulo
Country [11] 0 0
Brazil
State/province [11] 0 0
Porto Elegre
Country [12] 0 0
Canada
State/province [12] 0 0
Alberta
Country [13] 0 0
Canada
State/province [13] 0 0
British Columbia
Country [14] 0 0
Canada
State/province [14] 0 0
Nova Scotia
Country [15] 0 0
Canada
State/province [15] 0 0
Ontario
Country [16] 0 0
Canada
State/province [16] 0 0
Quebec
Country [17] 0 0
China
State/province [17] 0 0
Shanghai
Country [18] 0 0
Czech Republic
State/province [18] 0 0
Liberec
Country [19] 0 0
Czech Republic
State/province [19] 0 0
Pilsen
Country [20] 0 0
Czech Republic
State/province [20] 0 0
Prague
Country [21] 0 0
Czech Republic
State/province [21] 0 0
Praha
Country [22] 0 0
Czech Republic
State/province [22] 0 0
Usti nad Labem
Country [23] 0 0
Finland
State/province [23] 0 0
Kuopio
Country [24] 0 0
Finland
State/province [24] 0 0
Tampere
Country [25] 0 0
France
State/province [25] 0 0
Besancon
Country [26] 0 0
France
State/province [26] 0 0
Grenoble
Country [27] 0 0
France
State/province [27] 0 0
Paris
Country [28] 0 0
France
State/province [28] 0 0
Pau
Country [29] 0 0
Germany
State/province [29] 0 0
Bonn
Country [30] 0 0
Germany
State/province [30] 0 0
Essen
Country [31] 0 0
Germany
State/province [31] 0 0
Immenstadt
Country [32] 0 0
Germany
State/province [32] 0 0
Munchen
Country [33] 0 0
Greece
State/province [33] 0 0
Patras
Country [34] 0 0
Greece
State/province [34] 0 0
Thessaloniki
Country [35] 0 0
Hungary
State/province [35] 0 0
Budapest
Country [36] 0 0
Hungary
State/province [36] 0 0
Szeged
Country [37] 0 0
Korea, Republic of
State/province [37] 0 0
Cheonan
Country [38] 0 0
Korea, Republic of
State/province [38] 0 0
Gwangju
Country [39] 0 0
Korea, Republic of
State/province [39] 0 0
Seoul
Country [40] 0 0
Macedonia, The Former Yugoslav Republic of
State/province [40] 0 0
Skopje
Country [41] 0 0
Netherlands
State/province [41] 0 0
Nieuwegein
Country [42] 0 0
New Zealand
State/province [42] 0 0
Hamilton
Country [43] 0 0
Serbia
State/province [43] 0 0
Belgrade
Country [44] 0 0
Spain
State/province [44] 0 0
Baldona
Country [45] 0 0
Spain
State/province [45] 0 0
Barcelona
Country [46] 0 0
Spain
State/province [46] 0 0
Madrid
Country [47] 0 0
Spain
State/province [47] 0 0
Palma de Mallorca
Country [48] 0 0
Spain
State/province [48] 0 0
Vigo
Country [49] 0 0
United Kingdom
State/province [49] 0 0
Basingstoke
Country [50] 0 0
United Kingdom
State/province [50] 0 0
Bethnal Green
Country [51] 0 0
United Kingdom
State/province [51] 0 0
Camberley
Country [52] 0 0
United Kingdom
State/province [52] 0 0
Hull
Country [53] 0 0
United Kingdom
State/province [53] 0 0
Kettering
Country [54] 0 0
United Kingdom
State/province [54] 0 0
Leicester
Country [55] 0 0
United Kingdom
State/province [55] 0 0
Manchester
Country [56] 0 0
United Kingdom
State/province [56] 0 0
Margate
Country [57] 0 0
United Kingdom
State/province [57] 0 0
Sheffield
Country [58] 0 0
United Kingdom
State/province [58] 0 0
Southampton
Country [59] 0 0
United Kingdom
State/province [59] 0 0
Taunton

Funding & Sponsors
Primary sponsor type
Other
Name
Population Health Research Institute
Address
Country

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Sanjit S. Jolly, MD, MSc, FRCP
Address 0 0
Hamilton Health Sciences Corporation
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

TypeCitations or Other Details
Journal Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Ro... [More Details]

Results not provided in https://clinicaltrials.gov/study/NCT01149044